Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
By C. Tognon, S. Knezevich, D. Huntsman, C. Roskelley, N. Melnyk, J. Mathers, L. Becker, F. Carneiro, N. Macpherson, D. Horsman and 2 more. Cancer Cell, 2002
873 citations recorded by the source corpus.
Subfields: Cell Biology, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/eb66cef06d16d8f58de220a2af86bd42c6cbbf19
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data (2011, background): “The discovery of the EML4-ALK fusion in non-small-cell lung cancer and the ETV6NTRK3 fusion in human secretory breast carcinoma suggest that gene fusions are also recurrent at low levels in other solid tumor types [3,4].”
- Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity (2010, background): “’’ In addition, it has recently been shown that SC of the breast harbors a recurrent balanced chromosomal translocation, t(12;15) (p13;q25) ETV6-NTRK3, which leads to a fusion gene, comprising the ETV6 gene on chromosome 12 and the NTRK3 gene on chromosome 15.(31) The fusion gene, ETV6-NTRK3, encode”